X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2422) 2422
Publication (165) 165
Book Review (20) 20
Magazine Article (19) 19
Book Chapter (14) 14
Conference Proceeding (12) 12
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematinics - therapeutic use (2438) 2438
humans (2383) 2383
female (1216) 1216
anemia - drug therapy (1137) 1137
erythropoietin - therapeutic use (1110) 1110
index medicus (1087) 1087
male (1064) 1064
anemia (901) 901
middle aged (819) 819
anemia - etiology (728) 728
aged (712) 712
recombinant proteins (650) 650
adult (568) 568
epoetin alfa (558) 558
treatment outcome (525) 525
urology & nephrology (488) 488
erythropoietin (473) 473
recombinant-human-erythropoietin (418) 418
hematinics - adverse effects (389) 389
erythropoietin - analogs & derivatives (372) 372
darbepoetin alfa (370) 370
hemoglobins - metabolism (357) 357
hematinics - administration & dosage (337) 337
kidney failure, chronic - complications (325) 325
oncology (322) 322
hemoglobin (313) 313
anemia - blood (296) 296
renal dialysis (291) 291
chronic kidney-disease (282) 282
epoetin-alpha (282) 282
hemoglobins - analysis (280) 280
risk factors (278) 278
kidney failure, chronic - therapy (264) 264
quality-of-life (263) 263
quality of life (262) 262
double-blind (260) 260
aged, 80 and over (259) 259
mortality (251) 251
retrospective studies (244) 244
care and treatment (226) 226
hemodialysis (217) 217
medicine, general & internal (217) 217
blood transfusion (216) 216
neoplasms - complications (215) 215
prospective studies (215) 215
folic acid - therapeutic use (214) 214
hemodialysis-patients (213) 213
time factors (213) 213
anemia - therapy (212) 212
cancer (210) 210
chronic kidney disease (210) 210
neoplasms - drug therapy (209) 209
anemia - chemically induced (208) 208
anemia, iron-deficiency - drug therapy (206) 206
pharmacology & pharmacy (206) 206
antineoplastic agents - adverse effects (201) 201
iron - therapeutic use (194) 194
erythropoiesis-stimulating agents (191) 191
erythropoietin - adverse effects (189) 189
therapy (185) 185
renal insufficiency, chronic - complications (175) 175
erythropoietin - administration & dosage (174) 174
hematology (173) 173
iron (172) 172
practice guidelines as topic (171) 171
adolescent (167) 167
chemotherapy (163) 163
chronic disease (160) 160
darbepoetin-alpha (159) 159
nephrology (158) 158
anemia - complications (155) 155
ferric compounds - therapeutic use (151) 151
medicine & public health (150) 150
randomized controlled trials as topic (145) 145
dose-response relationship, drug (143) 143
hematinics - economics (143) 143
united states (143) 143
health aspects (142) 142
erythropoiesis - drug effects (141) 141
anaemia (140) 140
prevalence (140) 140
dialysis (139) 139
animals (136) 136
intravenous iron (135) 135
kidney failure, chronic - blood (134) 134
renal dialysis - adverse effects (131) 131
anemia - diagnosis (130) 130
drug therapy (129) 129
recombinant proteins - therapeutic use (129) 129
chronic kidney failure (128) 128
transplantation (127) 127
biomarkers - blood (126) 126
drug administration schedule (126) 126
ferritins - blood (125) 125
research (123) 123
management (122) 122
placebo-controlled trial (120) 120
young adult (120) 120
analysis (119) 119
hematinics - pharmacology (119) 119
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2237) 2237
Spanish (46) 46
French (44) 44
Italian (19) 19
German (18) 18
Croatian (15) 15
Japanese (15) 15
Russian (14) 14
Hungarian (11) 11
Polish (6) 6
Dutch (3) 3
Portuguese (3) 3
Chinese (2) 2
Czech (2) 2
Swedish (2) 2
Bulgarian (1) 1
Danish (1) 1
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 14, pp. 1591 - 1597
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 8/2008, Volume 100, Issue 16, pp. 1155 - 1166
Journal Article
Journal of Oral Pathology & Medicine, ISSN 0904-2512, 07/2013, Volume 42, Issue 6, pp. 474 - 479
Journal Article
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 05/2010, Volume 5, Issue 5, pp. 905 - 911
Background and objectives: Vitamin D deficiency is highly prevalent in chronic kidney disease. The aim of this study was to evaluate the effects of oral... 
BRAIN NATRIURETIC PEPTIDE | 1,25-DIHYDROXYVITAMIN-D3 | 1-ALPHA-HYDROXYLASE | UROLOGY & NEPHROLOGY | 25-HYDROXYVITAMIN D3 | PREVALENCE | CHRONIC KIDNEY-DISEASE | VITAMIN-D DEFICIENCY | 1,25-DIHYDROXYCHOLECALCIFEROL | BLOOD-PRESSURE | CALCITRIOL | Prospective Studies | Vitamin D Deficiency - complications | Erythropoietin - therapeutic use | Humans | Middle Aged | Vitamin D Deficiency - drug therapy | Ergocalciferols - therapeutic use | Male | Polyamines - therapeutic use | Parathyroid Hormone - blood | Bone Remodeling - drug effects | Calcium - blood | Erythropoietin - analogs & derivatives | C-Reactive Protein - metabolism | Cholecalciferol - administration & dosage | Time Factors | Vitamin D Deficiency - blood | Female | Kidney Diseases - blood | Kidney Diseases - complications | Sevelamer | Chelating Agents - therapeutic use | Natriuretic Peptide, Brain - blood | Hematinics - therapeutic use | Hypertrophy, Left Ventricular - blood | Administration, Oral | Hypertrophy, Left Ventricular - etiology | Hypertrophy, Left Ventricular - prevention & control | Inflammation Mediators - blood | Bone Density Conservation Agents - therapeutic use | Kidney Diseases - drug therapy | Treatment Outcome | Biomarkers - blood | Calcitriol - blood | Vitamin D - blood | Phosphorus - blood | Kidney Diseases - therapy | Vitamin D - analogs & derivatives | Aged | Darbepoetin alfa | Chronic Disease | Dietary Supplements | Vitamins - administration & dosage | Renal Dialysis | Serum Albumin - metabolism | Original
Journal Article
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 2017, Volume 40, Issue 1, pp. 66 - 74
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2013, Volume 368, Issue 13, pp. 1210 - 1219
In this trial, patients with systolic heart failure and anemia were assigned to receive either darbepoetin alfa or placebo. At 28 months, there was no... 
MORTALITY | CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | CITY CARDIOMYOPATHY QUESTIONNAIRE | EPOETIN | MORBIDITY | REDUCTION | DOUBLE-BLIND | CHRONIC KIDNEY-DISEASE | Shock, Septic - etiology | Double-Blind Method | Heart Failure, Systolic - drug therapy | Hematinics - therapeutic use | Erythropoietin - therapeutic use | Heart Failure, Systolic - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Erythropoietin - adverse effects | Hematinics - adverse effects | Male | Thromboembolism - etiology | Erythropoietin - analogs & derivatives | Stroke - etiology | Anemia - drug therapy | Treatment Failure | Female | Aged | Darbepoetin alfa | Anemia - etiology | Hemoglobins - analysis | Heart Failure, Systolic - complications | Heart failure | Usage | Care and treatment | Anemia | Patient outcomes | Diagnosis | Clinical trials | Patient safety | Hemoglobin | Thromboembolism | Patients | Heart diseases | Cancer | Shock | Systolic/mortality | Hematinics/adverse effects | chronic heart failure | Erythropoietin/analogs & derivatives | Thromboembolism/etiology | Klinisk medicin | Heart Failure | Anemia/drug therapy | Hematinics/therapeutic use | Erythropoietin/therapeutic use | Hemoglobins/analysis | Anemia/etiology | Erythropoietin/adverse effects | Stroke/etiology | Clinical Medicine | Systolic/complications | Septic/etiology | Systolic/drug therapy
Journal Article